Modeling Hematopoiesis in MDS and AML with QSP
Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…
Certara2026 年 5 月 1 日
IO Simulator: A QSP Platform for Immuno-Oncology
This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…
Certara2026 年 4 月 30 日
QSP at an inflection point: Scaling impact
The QSP Summit at Certainty US 2026 brought together industry leaders to explore how Quantitative…
Certara2026 年 4 月 29 日
From models to impact: What QSPC 2026 revealed about the future of drug development
Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…
Certara2026 年 4 月 28 日
Modeling Hope: From Patient to Scientist Ellen Swanson on QSP, Breast Cancer, and Hope Through Science
Ellen Swanson, QSP Senior Scientist at Certara, shares her personal journey from breast cancer diagnosis…
Certara2026 年 4 月 16 日
Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation
Learn how early-stage biosimulation and mechanistic modeling enable smarter portfolio prioritization before IND-enabling studies. Watch…
Certara2026 年 3 月 25 日
ADC Development & Differentiation Strategies | Quantitative Systems Pharmacology & MIDD
Learn how model-informed drug development (MIDD) and quantitative systems pharmacology (QSP) support antibody-drug conjugate (ADC)…
Certara2026 年 3 月 13 日
Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development
Discover how Certara's AI-powered QSP modeling software, Certara IQ is overcoming challenges in drug development…
Certara2026 年 2 月 17 日
